By Counterforce Health Team in Uplizna (inebilizumab) —

How to Get Uplizna (Inebilizumab) Covered by Humana in California: Prior Authorization, Appeals, and State Protections

Answer Box: Your Path to Uplizna Coverage with Humana in California

Uplizna (inebilizumab) requires prior authorization from Humana Medicare Advantage and Part D plans in California. Your doctor submits the request through Humana's provider portal or by faxing 877-486-2621. Standard decisions take 7 days; expedited reviews (for urgent cases) take 72 hours. If denied, you have 65 days to appeal internally, then can request California's Independent Medical Review (IMR) through the DMHC for binding external review.

First step today: Have your prescribing specialist gather your AQP4-IgG positive test results (for NMOSD) or organ involvement documentation (for IgG4-RD), HBV screening, and prior therapy records to submit with the prior authorization request.

Table of Contents

  1. Coverage Basics
  2. Prior Authorization Process
  3. Timing and Deadlines
  4. Step Therapy Requirements
  5. Common Denial Reasons & Solutions
  6. Appeals Process in California
  7. Costs and Financial Assistance
  8. Specialty Pharmacy Requirements
  9. Frequently Asked Questions

Coverage Basics

Is Uplizna Covered by Humana?

Yes, Humana covers Uplizna (inebilizumab) for FDA-approved indications with prior authorization. The drug is approved for:

  • AQP4-IgG positive NMOSD in adults
  • IgG4-related disease (IgG4-RD) in adults (first FDA-approved therapy for this condition)
  • AChR- or MuSK-positive generalized myasthenia gravis in adults (approved December 2025)

All Humana Medicare Advantage and Part D plans require prior authorization due to the drug's high cost (approximately $140,248.50 per dose) and specialized administration requirements.

Coverage at a Glance

Requirement Details Where to Find It
Prior Authorization Required for all plans Humana PA Portal
Formulary Status Specialty tier (varies by plan) Humana Drug Lists
Step Therapy Rituximab preferred for NMOSD Part B Step Therapy List
Billing Code J1823 (Medicare Part B) CMS HCPCS
Specialty Pharmacy CenterWell required Plan documents

Prior Authorization Process

Who Can Submit the Request?

  • Prescribing physician (recommended approach)
  • Member (patient)
  • Appointed representative
  • Other authorized prescriber

Step-by-Step: Fastest Path to Approval

  1. Gather Required Documentation (Clinic)
    • AQP4-IgG positive lab results (for NMOSD) or confirmed organ involvement (for IgG4-RD)
    • HBV screening results (required safety check)
    • Documentation of prior therapy failures or contraindications
    • Current clinical notes and treatment plan
  2. Submit via Provider Portal (Prescriber)
    • Access Humana's Provider Portal
    • Use Prior Authorization Search Tool to confirm requirements
    • Upload all supporting documentation
  3. Alternative Submission Methods
    • Fax: 877-486-2621 (Part D requests)
    • Phone: 800-555-2546 (Mon-Fri, 8am-8pm local time)
    • Online: Member portal for patient-initiated requests
  4. Mark as Expedited if Urgent (When Applicable)
    • Check "expedited" box on submission
    • Include physician statement justifying urgency
    • Timeline reduces to 72 hours for decision
  5. Track Status (All Parties)
    • Provider portal shows real-time status
    • Members receive mailed decision letters
    • Follow up if no response within standard timeframes

Clinician Corner: Medical Necessity Letter Checklist

Your medical necessity letter should include:

  • Diagnosis confirmation with ICD-10 codes
  • Prior treatments attempted and specific reasons for failure/intolerance
  • Clinical rationale for Uplizna based on FDA labeling or recognized guidelines
  • Dosing plan (two 300mg infusions 2 weeks apart, then every 6 months)
  • Monitoring plan including infection surveillance
  • Treatment goals and expected outcomes
Tip: Reference Humana's specific medical coverage policies when available, as this demonstrates alignment with their own criteria.

Timing and Deadlines

Standard Timelines

Review Type Humana Decision Time Your Filing Deadline
Standard PA 7 calendar days Before treatment start
Expedited PA 72 hours When urgent need documented
Standard Appeal 7 calendar days 65 days from denial
Expedited Appeal 72 hours 65 days from denial

When to Request Expedited Review

Request expedited processing when:

  • Delay could seriously jeopardize your health
  • You're experiencing active NMOSD relapses
  • Current therapy is failing and hospitalization risk exists
  • You're transitioning from another B-cell depleting therapy

Step Therapy Requirements

For NMOSD patients: Humana's 2026 Part B step therapy policy designates rituximab as the preferred agent before approving Uplizna. However, exceptions apply if:

  • You have a paid claim for Uplizna within the past 365 days (grandfathering provision)
  • You've documented failure or intolerance to rituximab
  • You have contraindications to rituximab (e.g., severe infusion reactions)

Step Therapy Exception Process

  1. Document rituximab trial with specific dates, doses, and outcomes
  2. Submit exception request via the same PA portal
  3. Include peer-reviewed evidence supporting direct Uplizna use
  4. Request peer-to-peer review if initially denied
Note: The 365-day lookback period means patients already on Uplizna won't be forced to switch to rituximab during plan transitions.

Common Denial Reasons & Solutions

Denial Reason How to Overturn
"Not AQP4-IgG positive" Submit lab results showing positive AQP4-IgG antibodies
"Inadequate specialist involvement" Ensure neurologist or rheumatologist is prescribing
"Missing HBV screening" Complete HBV surface antigen, core antibody, and surface antibody tests
"Step therapy not met" Document rituximab failure/intolerance or request exception
"Not medically necessary" Submit comprehensive medical necessity letter with guidelines
"Billing/coding issues" Verify J1823 code and ensure proper site of care documentation

When Counterforce Health Can Help

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed rebuttals. Their platform identifies the specific denial basis and drafts point-by-point responses aligned to each plan's own rules, pulling the right medical evidence and operational details that payers expect for complex therapies like Uplizna.

Appeals Process in California

Internal Appeals (Level 1)

If your initial request is denied:

  1. File within 65 days of the denial notice
  2. Use Humana's Appeal Form available on their member portal
  3. Include new evidence addressing the specific denial reasons
  4. Request expedited review if clinically urgent

Submission options:

  • Phone: 800-867-6601
  • Mail: Humana Grievances and Appeals, P.O. Box 14546, Lexington, KY 40512-4546
  • Online: Member portal appeals section

California Independent Medical Review (IMR)

California's unique advantage: If Humana upholds the denial, you can request binding external review through California's Independent Medical Review system.

For DMHC-Regulated Plans (Most HMOs and Managed Care)

  1. File IMR application through healthhelp.ca.gov
  2. Timeline: 45 days for standard review, 72 hours for expedited
  3. No cost to the patient
  4. Binding decision - if approved, Humana must cover the treatment

Getting Help with Appeals

  • DMHC Help Center: 888-466-2219
  • Health Consumer Alliance: Nonprofit assistance for complex appeals
  • Counterforce Health: Professional appeal preparation services
From our advocates: "We've seen California's IMR process reverse many Uplizna denials, especially when the appeal includes peer-reviewed evidence showing the drug's effectiveness for the patient's specific condition and clear documentation of why alternatives aren't appropriate. The key is presenting a complete clinical picture that independent physicians can easily understand."

Costs and Financial Assistance

Understanding Your Costs

With a list price of approximately $140,248.50 per dose, Uplizna costs about:

  • Year 1: ~$420,000 (3 doses)
  • Subsequent years: ~$280,000 (2 doses annually)

Your out-of-pocket costs depend on:

  • Plan type (Medicare Advantage vs. Part D)
  • Formulary tier placement
  • Deductible status
  • Coverage phase (initial coverage, coverage gap, catastrophic)

Financial Assistance Options

Amgen By Your Side Program

  • Copay assistance for eligible patients
  • Patient services support: 1-866-467-4362
  • Appeals assistance and prior authorization support

Medicare Extra Help

  • Low-income subsidy program
  • Can significantly reduce or eliminate copays
  • Apply through Social Security Administration

Specialty Pharmacy Requirements

Humana typically requires Uplizna to be dispensed through CenterWell Specialty Pharmacy (Humana's specialty pharmacy network). This ensures:

  • Proper storage and handling of the medication
  • Coordination with your infusion center
  • Insurance verification and prior authorization management
  • Patient support services

If your prescription is transferred to specialty pharmacy, this is normal and doesn't indicate a problem with your coverage.

Frequently Asked Questions

How long does Humana prior authorization take in California? Standard requests take 7 calendar days; expedited requests take 72 hours. California doesn't have different timelines than other states for Medicare plans.

What if Uplizna isn't on my plan's formulary? You can request a formulary exception through the same prior authorization process. Include evidence that preferred alternatives are ineffective or inappropriate for your condition.

Can I appeal if I'm denied due to step therapy? Yes. Document why the preferred drug (typically rituximab) failed or isn't appropriate, and request a step therapy exception as part of your appeal.

Does my NMOSD need to be active to get approved? No. Uplizna is approved for preventing relapses in AQP4-IgG positive NMOSD, not just treating active disease. Include your relapse history and current disability status in the request.

What happens if I move to California from another state while on Uplizna? The 365-day lookback period should protect your coverage during plan transitions. Contact Humana immediately to ensure continuity of care.

Can my family doctor prescribe Uplizna? While technically possible, Humana typically requires specialist involvement (neurologist for NMOSD, rheumatologist for IgG4-RD) for approval. Having a specialist co-sign or take over prescribing often improves approval odds.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with Humana and consult your healthcare provider for medical decisions. For assistance with complex appeals, consider consulting with organizations like Counterforce Health that specialize in insurance coverage advocacy.

Need help with your appeal? Contact the California DMHC Help Center at 888-466-2219 or visit healthhelp.ca.gov for free assistance with insurance disputes.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.